“A joint study conducted by UNC Gillings School of Global Public Health and UNC School of Medicine shows that individuals previously infected with dengue virus could have key antibodies that protect against the Zika virus.”
This important update from Chapel Hill, North Carolina. “A new research study from University of North Carolina researchers shows that individuals who have been previously infected with a flavivirus – specifically dengue and Zika viruses – could have antibodies that protect against Zika.
“Those antibodies could be used to develop vaccines to protect against Zika, as well as therapies to treat the virus, according to the study, which was a collaboration between researchers at UNC’s Gillings School of Global Public Health and the UNC School of Medicine.
“The study, ‘"Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus":http://mbio.asm.org/content/7/4/e01123-16,’ was published in the July/August issue of mBio, the journal of the American Society for Microbiology.